Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...

Type I Diabetes I: Introduction

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...

Type I Diabetes II: Pathophysiology

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...

Type II Diabetes II: Pathophysiology

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.

Hyperglycemia

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The Vitamin D3 analogue calcipotriol suppresses CpG-activated TLR9-MyD88 signalling in murine plasmacytoid dendritic cells.

Clinical and experimental dermatology·2018

Same author

Updated results from GEST study: a randomized, three-arm phase III study for advanced pancreatic cancer.

Journal of cancer research and clinical oncology·2017

Same author

Factors controlling denitrification of mudflat sediments in Ariake Bay, Japan.

Environmental monitoring and assessment·2016

Same author

Randomised phase II trial of S-1 plus oxaliplatin vs S-1 in patients with gemcitabine-refractory pancreatic cancer.

British journal of cancer·2015

Same author

Repetitive sequences originating from the centromere constitute large-scale heterochromatin in the telomere region in the siamang, a small ape.

Heredity·2012

Same author

Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan.

British journal of cancer·2010

Same journal

A Kidney Transplant Recipient with Severe Chronic Diarrhea and Villous Atrophy.

Gastroenterology·2026

Same journal

A Clinical Perspective on Comparative Models of Pancreatic Cyst Surveillance.

Gastroenterology·2026

Same journal

Reply to Jiang et al.

Gastroenterology·2026

Same journal

An Unusual Cause of Chronic Hematochezia.

Gastroenterology·2026

Same journal

How important is fiber in the Crohn's disease story?

Gastroenterology·2026

Same journal

Reply to "Critical Appraisal of the Integrin αV-YAP-CTGF Axis in Congestive Hepatopathy".

Gastroenterology·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 18, 2026

Robotic Enucleation of an Intra-Pancreatic Insulinoma in the Pancreatic Head

Robotic Enucleation of an Intra-Pancreatic Insulinoma in the Pancreatic Head

Published on: January 3, 2020

Aberrant insulinoma in the duodenum.

K Miyazaki, A Funakoshi, S Nishihara

Gastroenterology

|May 1, 1986

Summary

This summary is machine-generated.

This study details a rare duodenal insulinoma causing hypoglycemia. Surgical removal of the duodenal tumor successfully resolved the patient's symptoms, confirming the diagnosis.

More Related Videos

Application of Robot-assisted Pancreaticobiliary Junction Resection in Benign Duodenal Tumors

Application of Robot-assisted Pancreaticobiliary Junction Resection in Benign Duodenal Tumors

Published on: December 20, 2024

Robotic Duodenum-preserving Total Pancreatic Head Resection for Intraductal Papillary Mucinous Neoplasms

Robotic Duodenum-preserving Total Pancreatic Head Resection for Intraductal Papillary Mucinous Neoplasms

Published on: April 17, 2026

Related Experiment Videos

Last Updated: Jun 18, 2026

Robotic Enucleation of an Intra-Pancreatic Insulinoma in the Pancreatic Head

Robotic Enucleation of an Intra-Pancreatic Insulinoma in the Pancreatic Head

Published on: January 3, 2020

Application of Robot-assisted Pancreaticobiliary Junction Resection in Benign Duodenal Tumors

Application of Robot-assisted Pancreaticobiliary Junction Resection in Benign Duodenal Tumors

Published on: December 20, 2024

Robotic Duodenum-preserving Total Pancreatic Head Resection for Intraductal Papillary Mucinous Neoplasms

Robotic Duodenum-preserving Total Pancreatic Head Resection for Intraductal Papillary Mucinous Neoplasms

Published on: April 17, 2026

Area of Science:

Endocrinology
Gastroenterology
Surgical Oncology

Background:

Insulinomas, rare pancreatic tumors, typically occur in the pancreas.
Aberrant locations, such as the duodenum, are exceptionally uncommon.
Hyperinsulinemia leading to hypoglycemia necessitates precise diagnosis and localization.

Observation:

A patient presented with hyperinsulinemia and hypoglycemic symptoms, exacerbated by fasting.
Diagnostic imaging (angiography, duodenoscopy) localized a submucosal tumor in the third portion of the duodenum.
Percutaneous transhepatic catheterization confirmed elevated insulin levels in the venous drainage of the tumor.

Findings:

Histologic and immunocytochemical analysis confirmed the duodenal tumor as an insulinoma.
Tumor insulin exhibited identical amino acid structure to human insulin.
Surgical resection of the duodenal insulinoma led to complete resolution of hypoglycemia.

Implications:

This case highlights the importance of considering ectopic insulinoma locations in diagnosing hyperinsulinemic hypoglycemia.
Advanced imaging and biochemical sampling are crucial for localizing rare tumors.
Successful surgical management of duodenal insulinomas is feasible and curative.